MONTREAL, QUEBEC, CANADA– – ProMetic Life Sciences Inc. today announced the signing of an agreement by ProMetic’s UK subsidiary, ProMetic Biosciences Ltd , with a multinational company looking to capture significant share of a well established and growing $1B market with a new and improved version of its already existing commercialized product.

Continued here:
ProMetic Enters Agreement to Improve Manufacturing Process for Second-Generation Biopharmaceutical Targeting $1B Market (CCNMatthews via Yahoo! Finance)